As of Jun 22, 2026, HSIC's PEG ratio of 8.44 reflects its valuation relative to its growth. This value reflects a P/E ratio of 23.62 measured against EPS growth of 2.8%. When compared to the trailing four-quarter average of 3.3, HSIC's PEG ratio shows a 156% increase.
Henry Schein's ten years historical PEG ratio has an average of 1.97. Compared to historical data, HSIC's 8.44 PE to growth ratio represents a rise of 328%. HSIC reached its maximum PEG ratio of 7.73 during the Mar 2026 quarter over the past ten years. The Mar 2020 quarter had the bottom reading at 0.22, indicating the most optimal growth-adjusted valuation.
| Year | PEG ratio | PE ratio | Growth YoY |
|---|---|---|---|
| 2025 | 3.21 | 23.14 | 7.2% |
| 2024 | N/A | 22.94 | -3.5% |
| 2023 | N/A | 23.81 | -19.5% |
| 2022 | N/A | 20.22 | -12.4% |
| 2021 | 0.28 | 16.61 | 59.4% |
| 2020 | N/A | 23.26 | -39.8% |
| 2019 | 0.42 | 14.17 | 33.9% |
| 2018 | 0.63 | 22.2 | 35.5% |
| 2017 | N/A | 26.98 | -17.5% |
| 2016 | 2.78 | 24.16 | 8.7% |
| 2015 | 6.32 | 27.18 | 4.3% |
| 2014 | 2.38 | 24.8 | 10.4% |
| 2013 | 1.74 | 22.79 | 13.1% |
| 2012 | 2.05 | 18.01 | 8.8% |
| 2011 | 1.24 | 15.79 | 12.7% |
| Year | PEG ratio | PE ratio | Growth YoY |
|---|---|---|---|
| Mar 2026 | 7.73 | 21.65 | 2.8% |
| Dec 2025 | 3.21 | 23.14 | 7.2% |
| Sep 2025 | 0.7 | 20.71 | 29.7% |
| Jun 2025 | 1.56 | 23.33 | 15% |
| Mar 2025 | 2.52 | 21.18 | 8.4% |
| Dec 2024 | N/A | 22.94 | -3.5% |
| Sep 2024 | N/A | 29.76 | -27.9% |
| Jun 2024 | N/A | 23.48 | -20.9% |
| Mar 2024 | N/A | 25.26 | -15.8% |
| Dec 2023 | N/A | 23.81 | -19.5% |
| Sep 2023 | N/A | 21.77 | -26.7% |
| Jul 2023 | N/A | 23.51 | -26.8% |
| Apr 2023 | N/A | 22.97 | -23.7% |
| Dec 2022 | N/A | 20.22 | -12.4% |
| Sep 2022 | 3.08 | 14.48 | 4.7% |
Measured against past performance, HSIC's PEG ratio is higher than its 3, 5 and 10-year averages.
Henry Schein's PEG of 8.44 is above the Healthcare sector average.
Compared to its peers, HSIC's PEG ratio is under CAH's but above MCK's and IDXX's.
| Stock name | PEG ratio | Market cap |
|---|---|---|
| MCK Mckesson Corp | 0.4 | $92.13B |
| WOOF Petco Health & Wellness Company Inc | 1.14 | $801.92M |
| IDXX Idexx Laboratories Inc | 1.55 | $42.78B |
| HSIC Henry Schein Inc | 8.55 | $9.08B |
| CAH Cardinal Health Inc | 17.17 | $52.83B |
| ACH Accendra Health Inc. | N/A | $235.88M |
HSIC's Jun 22, 2026 PEG ratio comes in at 8.44.
Historical data over a 3-year period places HSIC's average PEG ratio at 3.14.
Historical data over a 5-year period places HSIC's average PEG ratio at 2.35.
At 8.44, HSIC's current PEG ratio marks the highest value observed over the past ten years.
Currently, HSIC's PEG ratio stands 328% higher than its 10-year historical average.
Slow earnings growth combined with a high valuation pushes HSIC's PEG ratio to 8.44.
PEG equals PE divided by EPS growth (YoY TTM). As of Jun 22, 2026, Henry Schein has a P/E ratio of 23.62. Earnings grew at 2.8% over the TTM period ending Mar 2026. Applying the formula, this produces a price to earnings growth ratio of 8.44. PEG RATIO(8.44) = PE RATIO(23.62) / EPS GROWTH(2.8%)
All PEG ratio stats are based on quarterly TTM periods, unless otherwise specified.